Abstract
AbstractA series of novel 1,2,3‐triazole‐linked hexopyranosyl mono/double‐headed pyrimidine nucleosides from D‐glucose was synthesized by Cu(I)‐mediated [3+2] cycloaddition reactions (CuAAC) of mono/diazido 2,6‐anhydro‐glucoheptitol and propynylated pyrimidines in good yields. It was observed that all the four synthesized pyrimidine nucleosides were found to be non‐cytotoxic upto 500 μM concentration. The 1,2,3‐triazole‐linked hexopyranosyl mono/double‐headed pyrimidine nucleosides have shown significant suppression of Hepatitis B surface antigen (HBsAg) and Hepatitis B e‐antigen (HBeAg). Amongst all the synthesized compounds, nucleoside dimer 1‐[1‐(6′‐deoxy‐6′‐(4‐(1‐methyluracil)‐1,2,3‐triazol‐1‐yl)‐β‐D‐glucopyranosyl methyl)‐1,2,3‐triazol‐4‐yl]methyl‐uracil was found to be more effective against HBeAg. In the suppression of viral DNA level, all the four synthesized nucleoside analogues were comparable to known drug Entecavir (ETV) with IC50 value in the range of 8.39 μM–18.58 μM and are two folds significant as compared to control.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.